Articles
News, editorials, patient stories, and more.
This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer
A Lab-Engineered Molecule Named Celiacase Could Change How Celiac Disease Is Managed
Researchers in Barcelona have designed a molecule called celiacase that breaks down the most harmful gluten fragments inside the stomach, be...
Read More — A Lab-Engineered Molecule Named Celiacase Could Change How Celiac Disease Is Managed »New Phase 3 Trial Data Show IVIG Improves Outcomes in Autoimmune Encephalitis
Phase 3 data presented at AAN 2026 show that IVIG significantly improves response rates in autoimmune encephalitis patients who do not respo...
Read More — New Phase 3 Trial Data Show IVIG Improves Outcomes in Autoimmune Encephalitis »Nearly One in Four Autoimmune Hepatitis Patients Also Has Another Autoimmune Disease, Study Finds
A new study of 371 autoimmune hepatitis patients found nearly 24 percent also had extrahepatic autoimmune diseases, most commonly Sjogren's...
Read More — Nearly One in Four Autoimmune Hepatitis Patients Also Has Another Autoimmune Disease, Study Finds »
Blog
Best Supplements for Hashimoto's Thyroiditis: What the Evidence Actually Says
Managing Hashimoto's thyroiditis often feels like assembling a puzzle with too many pieces. Thyroid medication is typically the foundation o...
Read More — Best Supplements for Hashimoto's Thyroiditis: What the Evidence Actually Says »Rezpeg Produces Meaningful Hair Regrowth at One Year in Severe Alopecia Areata, Phase 3 Plans Announced
Extended treatment with Nektar Therapeutics' rezpegaldesleukin produced clinically meaningful hair regrowth in 27% of participants with seve...
Read More — Rezpeg Produces Meaningful Hair Regrowth at One Year in Severe Alopecia Areata, Phase 3 Plans Announced »
Blog
How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness
Fifteen minutes is not a lot of time, especially when you're managing a complex chronic illness with multiple symptoms, multiple medications...
Read More — How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness »
Blog
What Is a Flare, Really?
The word "flare" gets used constantly in autoimmune communities, but it rarely gets a clear definition. If you've been told your disease is...
Read More — What Is a Flare, Really? »Subcutaneous TEPEZZA Hits the Mark in Phase 3 Trial for Thyroid Eye Disease
Amgen announced that a subcutaneous, on-body injector version of TEPEZZA met its primary and key secondary endpoints in a Phase 3 trial for...
Read More — Subcutaneous TEPEZZA Hits the Mark in Phase 3 Trial for Thyroid Eye Disease »
Blog
Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable
Living with an autoimmune disease often means navigating fatigue, joint pain, brain fog, and other unpredictable symptoms. But that doesn’...
Read More — Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable »Phase 3 VALOR Trial Published in NEJM: Brepocitinib Delivers Landmark Results in Dermatomyositis
The Phase 3 VALOR trial, published in the New England Journal of Medicine, found that brepocitinib 30 mg significantly outperformed placebo...
Read More — Phase 3 VALOR Trial Published in NEJM: Brepocitinib Delivers Landmark Results in Dermatomyositis »FDA Grants Fast Track Status to Allogene’s Autoimmune Therapy
FDA fast track designation highlights potential new cell therapy for autoimmune diseases.
Read More — FDA Grants Fast Track Status to Allogene’s Autoimmune Therapy »All 10 Evaluable Patients Achieve Insulin Independence in Eledon's Type 1 Diabetes Islet Transplant Trial
Updated results from UChicago Medicine show that all 10 evaluable patients who received islet transplants supported by tegoprubart achieved...
Read More — All 10 Evaluable Patients Achieve Insulin Independence in Eledon's Type 1 Diabetes Islet Transplant Trial »